Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome

Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease with high prevalence and possible poor prognosis. Though the pathogenesis of pSS has not been fully elucidated, B cell hyperactivity is considered as one of the fundamental abnormalities in pSS patients. It has long been identifi...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 136; no. 19; pp. 2297 - 2306
Main Authors Li, Mucong, Li, Mengtao, Qiao, Lin, Wu, Chanyuan, Xu, Dong, Zhao, Yan, Zeng, Xiaofeng
Format Journal Article
LanguageEnglish
Published China Lippincott Williams & Wilkins 05.10.2023
Lippincott Williams & Wilkins Ovid Technologies
Wolters Kluwer
Subjects
Apoptosis
Arthritis
Autoimmune diseases
Cells
Cytokines
Deoxyribonucleic acid
DNA
Drugs
Epigenetics
Exocrine glands
Genes
Granulocytes
Humans
Immune system
Janus Kinases - metabolism
Kinases
Lymphocytes
Lymphoma
Nervous system
Pathogenesis
Proteins
Review
Ribonucleic acid
RNA
Signal Transduction
Sjogren's Syndrome - drug therapy
Sjogren's Syndrome - metabolism
Skin diseases
STAT Transcription Factors - metabolism
STAT1 Transcription Factor - metabolism
STAT3 Transcription Factor - metabolism
Tumor necrosis factor-TNF
Online AccessGet full text

Cover

Abstract Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease with high prevalence and possible poor prognosis. Though the pathogenesis of pSS has not been fully elucidated, B cell hyperactivity is considered as one of the fundamental abnormalities in pSS patients. It has long been identified that Janus kinases-signal transducer and activator of transcription (JAK-STAT) signaling pathway contributes to rheumatoid arthritis and systemic lupus erythematosus. Recently, increasing numbers of studies have provided evidence that JAK-STAT pathway also has an important role in the pathogenesis of pSS via direct or indirect activation of B cells. Signal transducer and activator of transcription 1 (STAT1), STAT3, and STAT5 activated by various cytokines and ribonucleic acid contribute to pSS development, respectively or synergically. These results reveal the potential application of Janus kinase inhibitors for treatment of pSS, which may fundamentally improve the quality of life and prognosis of patients with pSS.
AbstractList Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease with high prevalence and possible poor prognosis. Though the pathogenesis of pSS has not been fully elucidated, B cell hyperactivity is considered as one of the fundamental abnormalities in pSS patients. It has long been identified that Janus kinases-signal transducer and activator of transcription (JAK-STAT) signaling pathway contributes to rheumatoid arthritis and systemic lupus erythematosus. Recently, increasing numbers of studies have provided evidence that JAK-STAT pathway also has an important role in the pathogenesis of pSS via direct or indirect activation of B cells. Signal transducer and activator of transcription 1 (STAT1), STAT3, and STAT5 activated by various cytokines and ribonucleic acid contribute to pSS development, respectively or synergically. These results reveal the potential application of Janus kinase inhibitors for treatment of pSS, which may fundamentally improve the quality of life and prognosis of patients with pSS.
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease with high prevalence and possible poor prognosis. Though the pathogenesis of pSS has not been fully elucidated, B cell hyperactivity is considered as one of the fundamental abnormalities in pSS patients. It has long been identified that Janus kinases-signal transducer and activator of transcription (JAK-STAT) signaling pathway contributes to rheumatoid arthritis and systemic lupus erythematosus. Recently, increasing numbers of studies have provided evidence that JAK-STAT pathway also has an important role in the pathogenesis of pSS via direct or indirect activation of B cells. Signal transducer and activator of transcription 1 (STAT1), STAT3, and STAT5 activated by various cytokines and ribonucleic acid contribute to pSS development, respectively or synergically. These results reveal the potential application of Janus kinase inhibitors for treatment of pSS, which may fundamentally improve the quality of life and prognosis of patients with pSS.ABSTRACTPrimary Sjögren's syndrome (pSS) is a systemic autoimmune disease with high prevalence and possible poor prognosis. Though the pathogenesis of pSS has not been fully elucidated, B cell hyperactivity is considered as one of the fundamental abnormalities in pSS patients. It has long been identified that Janus kinases-signal transducer and activator of transcription (JAK-STAT) signaling pathway contributes to rheumatoid arthritis and systemic lupus erythematosus. Recently, increasing numbers of studies have provided evidence that JAK-STAT pathway also has an important role in the pathogenesis of pSS via direct or indirect activation of B cells. Signal transducer and activator of transcription 1 (STAT1), STAT3, and STAT5 activated by various cytokines and ribonucleic acid contribute to pSS development, respectively or synergically. These results reveal the potential application of Janus kinase inhibitors for treatment of pSS, which may fundamentally improve the quality of life and prognosis of patients with pSS.
Author Li, Mucong
Qiao, Lin
Li, Mengtao
Zeng, Xiaofeng
Wu, Chanyuan
Xu, Dong
Zhao, Yan
AuthorAffiliation Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
AuthorAffiliation_xml – name: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
Author_xml – sequence: 1
  givenname: Mucong
  surname: Li
  fullname: Li, Mucong
  organization: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
– sequence: 2
  givenname: Mengtao
  surname: Li
  fullname: Li, Mengtao
– sequence: 3
  givenname: Lin
  surname: Qiao
  fullname: Qiao, Lin
– sequence: 4
  givenname: Chanyuan
  surname: Wu
  fullname: Wu, Chanyuan
– sequence: 5
  givenname: Dong
  surname: Xu
  fullname: Xu, Dong
– sequence: 6
  givenname: Yan
  surname: Zhao
  fullname: Zhao, Yan
– sequence: 7
  givenname: Xiaofeng
  surname: Zeng
  fullname: Zeng, Xiaofeng
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37185152$$D View this record in MEDLINE/PubMed
BookMark eNqFksuO0zAUhiM0iLnAGyAUiQVsMvgSxzabUVVxGRiExJS1dRo7qUtqFzul6ovxArwYzjSMOt3gjY_s7__9H_mcZyfOO5NlzzG6xEjyN9Mv8hIdLMKofJSdEVaSglUlPjmoT7PzGJcDw3j1JDulHAuGGTnL1Dffmdw3-afJ5-J2Npnl0bYOOuvafA39Ygu73Lq70rfGmWhjDk7nfTDQr4zrB-062BWEXX67_PO7Dca9inncOR38yjzNHjfQRfNs3C-y7-_fzaYfi5uvH66nk5uirnDJC8MInoOuTAPzRiOOSgA2F1XNmOCkhkYL1GCiOU5IU1aUGC640GVqmhGJ6UV2vffVHpZqDKQ8WHV34EOrIPS27ozSFAQgqhsJVUlwLWpdagZUguB1qpPX1d5rvZmvjK5TlwG6B6YPb5xdqNb_UhgxKiSqksPr0SH4nxsTe7WysTZdB874TVRE4JIRyglP6MsjdOk3If3AQHHCkKwkTdSLw0j3Wf59ZALKPVAHH2MwzT2CkRrmRaV5UcfzkmRvj2S17aG3fmjMdv8Tj29ufdebEH90m60JamGg6xcDTlJyVEg5igqEGOf0L1Lh1Bw
CitedBy_id crossref_primary_10_3390_jcm12185873
crossref_primary_10_61186_umj_34_12_794
crossref_primary_10_1016_j_jphotobiol_2024_112908
crossref_primary_10_3389_fimmu_2023_1212330
crossref_primary_10_1152_ajpcell_00661_2023
Cites_doi 10.1093/rheumatology/kep141
10.1038/nrrheum.2018.1
10.1074/jbc.272.22.14017
10.1002/art.39480
10.1136/annrheumdis-2012-201381
10.1016/S2665-9913(19)30160-2
10.1038/icb.2008.70
10.1016/j.ajpath.2011.02.017
10.1038/nrrheum.2013.110
10.1016/j.cytogfr.2017.10.001
10.1007/s12026-016-8844-4
10.1093/rheumatology/key276
10.1093/rheumatology/keaa670
10.1002/acr.23917
10.1016/j.jaad.2021.12.067
10.1155/2018/8564215
10.1126/science.1075762
10.1016/j.jaut.2015.12.002
10.1111/cei.12614
10.7326/M13-1085
10.1002/art.20998
10.1007/s40259-019-00333-w
10.1136/annrheumdis-2021-222053
10.1007/s40262-016-0426-z
10.1111/cei.12377
10.21037/tau.2016.02.03
10.1016/j.mce.2017.05.033
10.1007/s12026-019-9067-2
10.1155/2015/243723
10.1016/S0092-8674(00)81443-9
10.1093/rheumatology/keac167
10.1016/j.cyto.2016.06.017
10.1074/jbc.M101177200
10.1007/s12016-016-8570-7
10.7150/ijms.17718
10.1016/j.immuni.2010.07.001
10.1016/j.cell.2012.09.016
10.1111/febs.13709
10.1002/eji.201747213
10.1136/annrheumdis-2018-214846
10.1136/annrheumdis-2013-204573
10.1038/cmi.2016.47
10.1038/s41584-021-00726-8
10.4049/jimmunol.0800276
10.3390/cells8080898
10.1016/j.tcb.2008.08.008
10.1007/s10753-018-0764-0
10.1016/j.clim.2019.04.009
10.1016/j.coph.2018.12.003
10.1016/j.autrev.2016.09.003
10.1002/acr.23303
10.1073/pnas.95.19.11107
10.3389/fendo.2017.00071
10.1084/jem.20041115
10.1007/s12026-016-8891-x
10.1016/S0049-0172(00)80016-5
10.1016/j.jaut.2013.02.002
10.1002/art.40589
10.1016/j.jaut.2012.09.003
10.1016/j.clim.2018.04.004
10.1111/cei.12643
10.1007/s40265-017-0701-9
10.1007/s10067-016-3250-9
10.1016/j.stemcr.2017.11.015
10.1038/nrrheum.2016.100
10.1080/15384101.2015.1093703
10.1016/j.cyto.2012.11.002
10.1038/ni.3691
10.1007/s000180050393
10.1136/annrheumdis-2016-209589
10.1093/rheumatology/kev005
10.1016/j.immuni.2015.04.014
10.1136/annrheumdis-2013-203991
10.1016/j.celrep.2016.08.051
10.1186/ar4682
10.1016/j.immuni.2011.12.015
10.1136/annrheumdis-2015-208659
10.1016/j.tem.2017.11.001
10.1016/j.cytogfr.2008.08.006
10.1002/art.40911
10.1136/annrheumdis-2017-212652
10.1002/art.22176
10.2478/rir-2022-0017
10.1080/21691401.2019.1626413
10.1038/s41598-019-45793-w
10.3390/ijms19113628
10.1186/gb-2004-5-12-253
10.1002/art.40093
10.1038/s41598-021-90569-w
10.1007/s10753-020-01322-w
10.1186/s12964-017-0177-y
10.1002/eji.201646680
10.1056/NEJMcp1702514
10.3389/fimmu.2019.00281
10.1016/j.jaut.2019.01.013
10.1016/j.clim.2016.03.010
10.1371/journal.pone.0077605
10.1016/S0140-6736(21)02251-0
10.3892/ijmm.2016.2843
10.3390/ijms19010171
10.1016/j.pharmthera.2018.07.003
10.1016/j.clim.2018.06.002
10.1126/science.8197455
10.1038/labinvest.3700487
10.1007/s10753-017-0662-x
10.2169/internalmedicine.3668-19
10.1093/rheumatology/kez142
10.1016/j.rdc.2017.06.002
10.1001/jama.2018.13103
10.1080/08916934.2018.1446525
10.1084/jem.179.4.1109
10.1155/2019/8142368
10.1002/eji.201646872
10.1080/1744666X.2017.1291342
10.4049/jimmunol.0801986
10.2217/bmm-2017-0297
10.1007/s12016-019-08743-y
10.1136/annrheumdis-2013-204653
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2023
Copyright_xml – notice: Lippincott Williams & Wilkins
– notice: Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
– notice: Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1097/CM9.0000000000002539
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2542-5641
EndPage 2306
ExternalDocumentID oai_doaj_org_article_d3a8a03df9a6421c8cd4d5a39a87ccd4
PMC10538906
37185152
10_1097_CM9_0000000000002539
00029330-990000000-00577
Genre Journal Article
Review
GroupedDBID ---
-05
-0E
0R~
29B
2WC
40I
5GY
5RE
5VR
5VS
6J9
7X7
88E
8FI
8FJ
92F
92I
92M
AAAAV
AAHPQ
AAIQE
AASCR
ABASU
ABCQX
ABDIG
ABUWG
ABVCZ
ABZZY
ACGFO
ACGFS
ACILI
ACXJB
ADGGA
ADHPY
ADPDF
AENEX
AFBFQ
AFDTB
AFKRA
AHMBA
AHQNM
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
ALIPV
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BENPR
BPHCQ
BQLVK
BVXVI
CCEZO
CCPQU
CHBEP
CIEJG
CW9
DIK
DIWNM
EBS
EEVPB
EJD
F5P
FA0
FCALG
FRP
FYUFA
GNXGY
GQDEL
GROUPED_DOAJ
GX1
HLJTE
HMCUK
HYE
IAO
IHR
IKREB
IPNFZ
JUIAU
KQ8
L7B
M1P
M48
OK1
OPUJH
OVD
OVDNE
OVEED
OXXIT
P2P
P6G
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RLZ
RNS
RPM
RT5
S..
T8U
TCJ
TEORI
TGQ
TR2
TSPGW
U1F
U5O
UKHRP
W2D
WFFXF
XSB
AAYXX
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c6147-e521bad6efabfd0704aa5b86c55872cafd80f12d716eff4632e7878d453952913
IEDL.DBID M48
ISSN 2542-5641
0366-6999
IngestDate Wed Aug 27 01:30:26 EDT 2025
Thu Aug 21 18:35:36 EDT 2025
Mon Jul 21 11:48:19 EDT 2025
Fri Jul 25 09:34:24 EDT 2025
Mon Jul 21 05:30:12 EDT 2025
Thu Jul 03 08:31:58 EDT 2025
Thu Apr 24 23:20:21 EDT 2025
Fri May 16 03:50:31 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 19
Language English
License Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6147-e521bad6efabfd0704aa5b86c55872cafd80f12d716eff4632e7878d453952913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1097/CM9.0000000000002539
PMID 37185152
PQID 2872509693
PQPubID 2042885
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_d3a8a03df9a6421c8cd4d5a39a87ccd4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10538906
proquest_miscellaneous_2814523727
proquest_journals_2872509693
pubmed_primary_37185152
crossref_primary_10_1097_CM9_0000000000002539
crossref_citationtrail_10_1097_CM9_0000000000002539
wolterskluwer_health_00029330-990000000-00577
PublicationCentury 2000
PublicationDate 2023-10-05
PublicationDateYYYYMMDD 2023-10-05
PublicationDate_xml – month: 10
  year: 2023
  text: 2023-10-05
  day: 05
PublicationDecade 2020
PublicationPlace China
PublicationPlace_xml – name: China
– name: Baltimore
– name: Hagerstown, MD
PublicationTitle Chinese medical journal
PublicationTitleAlternate Chin Med J (Engl)
PublicationYear 2023
Publisher Lippincott Williams & Wilkins
Lippincott Williams & Wilkins Ovid Technologies
Wolters Kluwer
Publisher_xml – name: Lippincott Williams & Wilkins
– name: Lippincott Williams & Wilkins Ovid Technologies
– name: Wolters Kluwer
References Both (R13-20250602) 2017; 14
Maria (R119-20250602) 2017; 76
Lee (R93-20250602) 2018; 70
Bulosan (R67-20250602) 2009; 87
Pertovaara (R65-20250602) 2016; 165
Groner (R37-20250602) 2017; 451
Singh (R16-20250602) 2016; 68
Liu (R73-20250602) 2022
Qin (R87-20250602) 2009; 183
van Nimwegen (R113-20250602) 2020; 2
Jin (R7-20250602) 2013; 8
Brkic (R76-20250602) 2013; 72
Long (R98-20250602) 2019; 99
Vartoukian (R91-20250602) 2014; 177
Price (R121-20250602) 2022; 61
Imgenberg-Kreuz (R12-20250602) 2018; 196
Nicolas (R33-20250602) 2013; 2
Calautti (R58-20250602) 2018; 19
Villarino (R45-20250602) 2017; 18
Chen (R83-20250602) 2018; 19
Mariette (R3-20250602) 2018; 378
Konsta (R80-20250602) 2016; 53
Dela Cruz (R90-20250602) 2021; 11
Stephanou (R63-20250602) 2001; 276
Thabet (R81-20250602) 2013; 41
Welsch (R57-20250602) 2017; 47
Fujimura (R86-20250602) 2017; 52
Sengupta (R28-20250602) 1998; 95
Hirahara (R49-20250602) 2015; 42
Li (R30-20250602) 2008; 18
Alunno (R29-20250602) 2019; 8
Sallusto (R68-20250602) 1994; 179
Banerjee (R31-20250602) 2017; 77
Konsta (R79-20250602) 2016; 68
Babon (R88-20250602) 2012; 36
Yamaoka (R21-20250602) 2004; 5
Gurzov (R34-20250602) 2016; 283
Saraux (R14-20250602) 2016; 12
Richmond (R42-20250602) 2018; 10
Ma (R44-20250602) 2018; 77
Jara (R55-20250602) 2017; 65
Piessevaux (R89-20250602) 2008; 19
Takasawa (R85-20250602) 2018; 66
Aletaha (R18-20250602) 2018; 320
Vogelsang (R69-20250602) 2014; 16
Yu (R48-20250602) 2015; 14
Pertovaara (R92-20250602) 2015; 181
Manning (R22-20250602) 2002; 298
Baldini (R11-20250602) 2018; 12
Killedar (R66-20250602) 2006; 86
Zhao (R54-20250602) 2017; 14
Darnell (R24-20250602) 1994; 264
Ferrao (R23-20250602) 2017; 8
Fox (R106-20250602) 2021; 60
de la Varga Martínez (R52-20250602) 2017; 47
Wakamatsu (R64-20250602) 2006; 54
Gliozzi (R97-20250602) 2013; 40
Lin (R40-20250602) 2016; 5
Lagos (R78-20250602) 2018; 196
Bowman (R115-20250602) 2022; 399
Haacke (R111-20250602) 2017; 35
Smolen (R15-20250602) 2014; 73
Ciccia (R74-20250602) 2015; 181
Aota (R71-20250602) 2018; 41
Nocturne (R9-20250602) 2018; 14
Qiao (R43-20250602) 2016; 16
Meijer (R1-20250602) 2009; 48
Skudalski (R122-20250602) 2022; 87
Samotij (R19-20250602) 2019; 2019
Pijet (R39-20250602) 2013; 61
Misery (R59-20250602) 2019; 46
Devauchelle-Pensec (R107-20250602) 2014; 160
Aota (R117-20250602) 2021; 44
Yu (R27-20250602) 1997; 272
Brahmachari (R70-20250602) 2009; 183
Nocturne (R118-20250602) 2013; 9
Davies (R82-20250602) 2019; 10
Vivino (R105-20250602) 2019; 203
Itoh (R103-20250602) 2019; 59
Choy (R17-20250602) 2017; 69
Chu (R114-20250602) 2020; 72
Bai (R120-20250602) 2022; 81
Olivera (R62-20250602) 2017; 13
Mariette (R110-20250602) 2015; 74
Chen (R10-20250602) 2016; 15
Chen (R26-20250602) 1998; 93
Farlik (R46-20250602) 2010; 33
Bowman (R108-20250602) 2017; 69
Ciofani (R47-20250602) 2012; 151
Soendergaard (R56-20250602) 2018; 192
Yu (R20-20250602) 2017; 56
Goules (R2-20250602) 2017; 65
Margaretten (R4-20250602) 2017; 43
T. Virtanen (R60-20250602) 2019; 33
Seif (R32-20250602) 2017; 15
Xie (R104-20250602) 2019; 78
Båve (R6-20250602) 2005; 52
Soundharrajan (R38-20250602) 2019; 9
Ma (R95-20250602) 2004; 200
Aota (R72-20250602) 2018; 41
Fragoulis (R61-20250602) 2019; 58
Skopouli (R5-20250602) 2000; 29
Xin (R99-20250602) 2019; 47
Alunno (R8-20250602) 2015; 2015
Dodington (R35-20250602) 2018; 29
Gandolfo (R116-20250602) 2022; 3
Imgenberg-Kreuz (R75-20250602) 2016; 75
Barrera (R84-20250602) 2021; 60
Decker (R25-20250602) 1999; 55
Yang (R50-20250602) 2017; 39
Charras (R77-20250602) 2019; 58
Meshaal (R53-20250602) 2016; 35
Wen (R96-20250602) 2011; 178
Jere (R41-20250602) 2017; 38
Salaffi (R51-20250602) 2018; 2018
Tanaka (R101-20250602) 2022; 18
Meiners (R112-20250602) 2014; 73
Charles-Schoeman (R102-20250602) 2019; 71
Pontarini (R109-20250602) 2015; 54
Aqrawi (R100-20250602) 2018; 51
Davies (R94-20250602) 2018; 48
Pencik (R36-20250602) 2016; 87
References_xml – start-page: keac304
  year: 2022
  ident: R73-20250602
  article-title: TOX promotes follicular helper T cell differentiation in patients with primary Sjögren's syndrome
  publication-title: Rheumatology (Oxford)
– volume: 48
  start-page: 1077
  year: 2009
  ident: R1-20250602
  article-title: Health-related quality of life, employment and disability in patients with Sjogren's syndrome
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kep141
– volume: 14
  start-page: 133
  year: 2018
  ident: R9-20250602
  article-title: B cells in the pathogenesis of primary Sjögren syndrome
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2018.1
– volume: 272
  start-page: 14017
  year: 1997
  ident: R27-20250602
  article-title: Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.272.22.14017
– volume: 68
  start-page: 1
  year: 2016
  ident: R16-20250602
  article-title: 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39480
– volume: 72
  start-page: 728
  year: 2013
  ident: R76-20250602
  article-title: Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-201381
– volume: 2
  start-page: E153
  year: 2020
  ident: R113-20250602
  article-title: Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)
  publication-title: Lancet Rheumatol
  doi: 10.1016/S2665-9913(19)30160-2
– volume: 87
  start-page: 81
  year: 2009
  ident: R67-20250602
  article-title: Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset
  publication-title: Immunol Cell Biol
  doi: 10.1038/icb.2008.70
– volume: 178
  start-page: 2866
  year: 2011
  ident: R96-20250602
  article-title: Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2011.02.017
– volume: 9
  start-page: 544
  year: 2013
  ident: R118-20250602
  article-title: Advances in understanding the pathogenesis of primary Sjögren's syndrome
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.110
– volume: 38
  start-page: 73
  year: 2017
  ident: R41-20250602
  article-title: The JAK/STAT signaling pathway and photobiomodulation in chronic wound healing
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2017.10.001
– volume: 65
  start-page: 331
  year: 2017
  ident: R2-20250602
  article-title: Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers
  publication-title: Immunol Res
  doi: 10.1007/s12026-016-8844-4
– volume: 58
  start-page: i43
  year: 2019
  ident: R61-20250602
  article-title: JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/key276
– volume: 60
  start-page: 1951
  year: 2021
  ident: R84-20250602
  article-title: Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sjögren's syndrome
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keaa670
– volume: 72
  start-page: 1011
  year: 2020
  ident: R114-20250602
  article-title: Meta-analysis of treatment for primary Sjögren's syndrome
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.23917
– volume: 87
  start-page: 1
  year: 2022
  ident: R122-20250602
  article-title: Emerging therapeutics in the management of connective tissue disease. Part I. lupus erythematosus and Sjögren's syndrome
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2021.12.067
– volume: 2018
  start-page: 8564215
  year: 2018
  ident: R51-20250602
  article-title: Chronic pain in inflammatory arthritis: mechanisms, metrology, and emerging targets-A focus on the JAK-STAT pathway
  publication-title: Pain Res Manag
  doi: 10.1155/2018/8564215
– volume: 298
  start-page: 1912
  year: 2002
  ident: R22-20250602
  article-title: The protein kinase complement of the human genome
  publication-title: Science
  doi: 10.1126/science.1075762
– volume: 68
  start-page: 30
  year: 2016
  ident: R79-20250602
  article-title: Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2015.12.002
– volume: 181
  start-page: 29
  year: 2015
  ident: R92-20250602
  article-title: STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12614
– volume: 160
  start-page: 233
  year: 2014
  ident: R107-20250602
  article-title: Treatment of primary Sjögren syndrome with rituximab: a randomized trial
  publication-title: Ann Intern Med
  doi: 10.7326/M13-1085
– volume: 52
  start-page: 1185
  year: 2005
  ident: R6-20250602
  article-title: Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20998
– volume: 33
  start-page: 15
  year: 2019
  ident: R60-20250602
  article-title: Selective JAKinibs: prospects in inflammatory and autoimmune diseases
  publication-title: BioDrugs
  doi: 10.1007/s40259-019-00333-w
– volume: 81
  start-page: 1050
  year: 2022
  ident: R120-20250602
  article-title: Pilot study of baricitinib for active Sjogren's syndrome
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2021-222053
– volume: 56
  start-page: 107
  year: 2017
  ident: R20-20250602
  article-title: Clinical pharmacokinetics and pharmacodynamics of biologic therapeutics for treatment of systemic lupus erythematosus
  publication-title: Clin Pharmacokinet
  doi: 10.1007/s40262-016-0426-z
– volume: 177
  start-page: 618
  year: 2014
  ident: R91-20250602
  article-title: Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12377
– volume: 5
  start-page: 167
  year: 2016
  ident: R40-20250602
  article-title: Brain-derived neurotrophic factor promotes nerve regeneration by activating the JAK/STAT pathway in schwann cells
  publication-title: Transl Androl Urol
  doi: 10.21037/tau.2016.02.03
– volume: 451
  start-page: 1
  year: 2017
  ident: R37-20250602
  article-title: Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2017.05.033
– volume: 66
  start-page: 800
  year: 2018
  ident: R85-20250602
  article-title: Expression of human REG family genes in inflammatory bowel disease and their molecular mechanism
  publication-title: Immunol Res
  doi: 10.1007/s12026-019-9067-2
– volume: 2015
  start-page: 243723
  year: 2015
  ident: R8-20250602
  article-title: T regulatory and T helper 17 cells in primary Sjögren's syndrome: facts and perspectives
  publication-title: Mediators Inflamm
  doi: 10.1155/2015/243723
– volume: 93
  start-page: 827
  year: 1998
  ident: R26-20250602
  article-title: Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81443-9
– volume: 61
  start-page: 4797
  year: 2022
  ident: R121-20250602
  article-title: Safety and efficacy of filgotinib, lanraplenib, and tirabrutinib in Sjögren's syndrome: randomised, phase 2, double-blind, placebo-controlled study
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keac167
– volume: 87
  start-page: 26
  year: 2016
  ident: R36-20250602
  article-title: JAK-STAT signaling in cancer: from cytokines to non-coding genome
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2016.06.017
– volume: 276
  start-page: 28340
  year: 2001
  ident: R63-20250602
  article-title: Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M101177200
– volume: 52
  start-page: 351
  year: 2017
  ident: R86-20250602
  article-title: Significance of interleukin-6/STAT pathway for the gene expression of REG Iα, a new autoantigen in Sjögren's syndrome patients, in salivary duct epithelial cells
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-016-8570-7
– volume: 14
  start-page: 191
  year: 2017
  ident: R13-20250602
  article-title: Reviewing primary Sjögren's syndrome: beyond the dryness – from pathophysiology to diagnosis and treatment
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.17718
– volume: 33
  start-page: 25
  year: 2010
  ident: R46-20250602
  article-title: Nonconventional initiation complex assembly by STAT and NF-kappaB transcription factors regulates nitric oxide synthase expression
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.07.001
– volume: 151
  start-page: 289
  year: 2012
  ident: R47-20250602
  article-title: A validated regulatory network for Th17 cell specification
  publication-title: Cell
  doi: 10.1016/j.cell.2012.09.016
– volume: 283
  start-page: 3002
  year: 2016
  ident: R34-20250602
  article-title: The JAK/STAT pathway in obesity and diabetes
  publication-title: FEBS J
  doi: 10.1111/febs.13709
– volume: 48
  start-page: 1217
  year: 2018
  ident: R94-20250602
  article-title: Aberrant cell signalling in PBMCs upon IFN-( stimulation in primary Sjögren's syndrome patients associates with type I interferon signature
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201747213
– volume: 78
  start-page: 1048
  year: 2019
  ident: R104-20250602
  article-title: Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2018-214846
– volume: 73
  start-page: 492
  year: 2014
  ident: R15-20250602
  article-title: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204573
– volume: 14
  start-page: 842
  year: 2017
  ident: R54-20250602
  article-title: Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2016.47
– volume: 18
  start-page: 133
  year: 2022
  ident: R101-20250602
  article-title: Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-021-00726-8
– volume: 183
  start-page: 2045
  year: 2009
  ident: R70-20250602
  article-title: Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0800276
– volume: 8
  start-page: 898
  year: 2019
  ident: R29-20250602
  article-title: Pathogenic and therapeutic relevance of JAK/STAT signaling in systemic lupus erythematosus: integration of distinct inflammatory pathways and the prospect of their inhibition with an oral agent
  publication-title: Cells
  doi: 10.3390/cells8080898
– volume: 18
  start-page: 545
  year: 2008
  ident: R30-20250602
  article-title: Canonical and non-canonical JAK-STAT signaling
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2008.08.008
– volume: 41
  start-page: 1172
  year: 2018
  ident: R72-20250602
  article-title: Distinct regulation of CXCL10 production by cytokines in human salivary gland ductal and acinar cells
  publication-title: Inflammation
  doi: 10.1007/s10753-018-0764-0
– volume: 203
  start-page: 81
  year: 2019
  ident: R105-20250602
  article-title: Sjogren's syndrome: an update on disease pathogenesis, clinical manifestations and treatment
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2019.04.009
– volume: 46
  start-page: 7
  year: 2019
  ident: R59-20250602
  article-title: Current pharmaceutical developments in atopic dermatitis
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2018.12.003
– volume: 15
  start-page: 1171
  year: 2016
  ident: R10-20250602
  article-title: The role of microRNAs in the pathogenesis of autoimmune diseases
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2016.09.003
– volume: 69
  start-page: 1484
  year: 2017
  ident: R17-20250602
  article-title: Treatment of rheumatoid arthritis with anti-tumor necrosis factor or tocilizumab therapy as first biologic agent in a global comparative observational study
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.23303
– volume: 95
  start-page: 11107
  year: 1998
  ident: R28-20250602
  article-title: Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.95.19.11107
– volume: 8
  start-page: 71
  year: 2017
  ident: R23-20250602
  article-title: The Janus kinase (JAK) FERM and SH2 domains: bringing specificity to JAK-receptor interactions
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2017.00071
– volume: 200
  start-page: 1337
  year: 2004
  ident: R95-20250602
  article-title: Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection
  publication-title: J Exp Med
  doi: 10.1084/jem.20041115
– volume: 65
  start-page: 512
  year: 2017
  ident: R55-20250602
  article-title: Prolactin has a pathogenic role in systemic lupus erythematosus
  publication-title: Immunol Res
  doi: 10.1007/s12026-016-8891-x
– volume: 29
  start-page: 296
  year: 2000
  ident: R5-20250602
  article-title: Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/S0049-0172(00)80016-5
– volume: 41
  start-page: 175
  year: 2013
  ident: R81-20250602
  article-title: Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2013.02.002
– volume: 70
  start-page: 2057
  year: 2018
  ident: R93-20250602
  article-title: JAK-1 inhibition suppresses interferon-induced BAFF production in human salivary gland: potential therapeutic strategy for primary Sjögren's syndrome
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.40589
– volume: 40
  start-page: 122
  year: 2013
  ident: R97-20250602
  article-title: A link between interferon and augmented plasmin generation in exocrine gland damage in Sjögren's syndrome
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2012.09.003
– volume: 196
  start-page: 12
  year: 2018
  ident: R12-20250602
  article-title: Epigenetic alterations in primary Sjögren's syndrome – an overview
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2018.04.004
– volume: 181
  start-page: 219
  year: 2015
  ident: R74-20250602
  article-title: Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12643
– volume: 77
  start-page: 521
  year: 2017
  ident: R31-20250602
  article-title: JAK–STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects
  publication-title: Drugs
  doi: 10.1007/s40265-017-0701-9
– volume: 35
  start-page: 1515
  year: 2016
  ident: R53-20250602
  article-title: Signal transducer and activator of transcription 5 is implicated in disease activity in adult and juvenile onset systemic lupus erythematosus
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-016-3250-9
– volume: 10
  start-page: 17
  year: 2018
  ident: R42-20250602
  article-title: JAK/STAT-1 signaling is required for reserve intestinal stem cell activation during intestinal regeneration following acute inflammation
  publication-title: Stem Cell Reports
  doi: 10.1016/j.stemcr.2017.11.015
– volume: 12
  start-page: 456
  year: 2016
  ident: R14-20250602
  article-title: Treatment of primary Sjögren syndrome
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2016.100
– volume: 14
  start-page: 3362
  year: 2015
  ident: R48-20250602
  article-title: IL-12 induced the generation of IL-21- and IFN-(-co-expressing poly-functional CD4+ T cells from human naive CD4+ T cells
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2015.1093703
– volume: 61
  start-page: 445
  year: 2013
  ident: R39-20250602
  article-title: Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2012.11.002
– volume: 18
  start-page: 374
  year: 2017
  ident: R45-20250602
  article-title: Mechanisms and consequences of Jak-STAT signaling in the immune system
  publication-title: Nat Immunol
  doi: 10.1038/ni.3691
– volume: 55
  start-page: 1535
  year: 1999
  ident: R25-20250602
  article-title: Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s000180050393
– volume: 76
  start-page: 721
  year: 2017
  ident: R119-20250602
  article-title: Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-209589
– volume: 54
  start-page: 1429
  year: 2015
  ident: R109-20250602
  article-title: Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kev005
– volume: 42
  start-page: 877
  year: 2015
  ident: R49-20250602
  article-title: Asymmetric action of STAT transcription factors drives transcriptional outputs and cytokine specificity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.04.014
– volume: 74
  start-page: 526
  year: 2015
  ident: R110-20250602
  article-title: Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203991
– volume: 16
  start-page: 3121
  year: 2016
  ident: R43-20250602
  article-title: IFN-γ induces histone 3 lysine 27 trimethylation in a small subset of promoters to stably silence gene expression in human macrophages
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2016.08.051
– volume: 16
  start-page: R166
  year: 2014
  ident: R69-20250602
  article-title: Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar4682
– volume: 36
  start-page: 239
  year: 2012
  ident: R88-20250602
  article-title: Suppression of cytokine signaling by SOCS3: Characterization of the mode of inhibition and the basis of its specificity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2011.12.015
– volume: 53
  start-page: 1
  year: 2016
  ident: R80-20250602
  article-title: Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression
  publication-title: Bull Group Int Rech Sci Stomatol Odontol
– volume: 75
  start-page: 2029
  year: 2016
  ident: R75-20250602
  article-title: Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2015-208659
– volume: 29
  start-page: 55
  year: 2018
  ident: R35-20250602
  article-title: JAK/STAT – emerging players in metabolism
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2017.11.001
– volume: 19
  start-page: 371
  year: 2008
  ident: R89-20250602
  article-title: The many faces of the SOCS box
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2008.08.006
– volume: 71
  start-page: 1450
  year: 2019
  ident: R102-20250602
  article-title: Risk factors for major adverse cardiovascular events in phase III and long-term extension studies of tofacitinib in patients with rheumatoid arthritis
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.40911
– volume: 77
  start-page: 1354
  year: 2018
  ident: R44-20250602
  article-title: Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2017-212652
– volume: 54
  start-page: 3476
  year: 2006
  ident: R64-20250602
  article-title: Overexpression of phosphorylated STAT-1alpha in the labial salivary glands of patients with Sjögren's syndrome
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22176
– volume: 3
  start-page: 95
  year: 2022
  ident: R116-20250602
  article-title: JAK/STAT pathway targeting in primary Sjögren syndrome
  publication-title: Rheumatol Immunol Res
  doi: 10.2478/rir-2022-0017
– volume: 47
  start-page: 2473
  year: 2019
  ident: R99-20250602
  article-title: Mirt2 functions in synergy with miR-377 to participate in inflammatory pathophysiology of Sjögren's syndrome
  publication-title: Artif Cells Nanomed Biotechnol
  doi: 10.1080/21691401.2019.1626413
– volume: 9
  start-page: 9307
  year: 2019
  ident: R38-20250602
  article-title: Modulation of osteogenic and myogenic differentiation by a phytoestrogen formononetin via p38MAPK-dependent JAK-STAT and smad-1/5/8 signaling pathways in mouse myogenic progenitor cells
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-45793-w
– volume: 19
  start-page: 3628
  year: 2018
  ident: R83-20250602
  article-title: Deciphering molecular and phenotypic changes associated with early autoimmune disease in the aire-deficient mouse model of Sjögren's syndrome
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms19113628
– volume: 5
  start-page: 253
  year: 2004
  ident: R21-20250602
  article-title: The Janus kinases (JAKs)
  publication-title: Genome Biol
  doi: 10.1186/gb-2004-5-12-253
– volume: 69
  start-page: 1440
  year: 2017
  ident: R108-20250602
  article-title: Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.40093
– volume: 11
  start-page: 11154
  year: 2021
  ident: R90-20250602
  article-title: Gene expression alterations in salivary gland epithelia of Sjögren's syndrome patients are associated with clinical and histopathological manifestations
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-90569-w
– volume: 44
  start-page: 206
  year: 2021
  ident: R117-20250602
  article-title: Inhibition of JAK-STAT signaling by baricitinib reduces interferon-(-induced CXCL10 production in human salivary gland ductal cells
  publication-title: Inflammation
  doi: 10.1007/s10753-020-01322-w
– volume: 15
  start-page: 23
  year: 2017
  ident: R32-20250602
  article-title: The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-017-0177-y
– volume: 47
  start-page: 1096
  year: 2017
  ident: R57-20250602
  article-title: Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201646680
– volume: 378
  start-page: 931
  year: 2018
  ident: R3-20250602
  article-title: Primary Sjögren's syndrome
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp1702514
– volume: 10
  start-page: 281
  year: 2019
  ident: R82-20250602
  article-title: Single cell based phosphorylation profiling identifies alterations in toll-like receptor 7 and 9 signaling in patients with primary Sjögren's syndrome
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00281
– volume: 99
  start-page: 1
  year: 2019
  ident: R98-20250602
  article-title: Clinical significance and immunobiology of IL-21 in autoimmunity
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.01.013
– volume: 165
  start-page: 60
  year: 2016
  ident: R65-20250602
  article-title: Cytokine-induced STAT1 activation is increased in patients with primary Sjögren's syndrome
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2016.03.010
– volume: 8
  start-page: e77605
  year: 2013
  ident: R7-20250602
  article-title: Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0077605
– volume: 399
  start-page: 161
  year: 2022
  ident: R115-20250602
  article-title: Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)02251-0
– volume: 39
  start-page: 307
  year: 2017
  ident: R50-20250602
  article-title: Matrine induces the apoptosis of fibroblast-like synoviocytes derived from rats with collagen-induced arthritis by suppressing the activation of the JAK/STAT signaling pathway
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2016.2843
– volume: 19
  start-page: 171
  year: 2018
  ident: R58-20250602
  article-title: Psoriasis: A STAT3-centric view
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms19010171
– volume: 192
  start-page: 100
  year: 2018
  ident: R56-20250602
  article-title: Targeting JAK-STAT signal transduction in IBD
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2018.07.003
– volume: 196
  start-page: 85
  year: 2018
  ident: R78-20250602
  article-title: Association of high 5-hydroxymethylcytosine levels with ten eleven translocation 2 overexpression and inflammation in Sjögren's syndrome patients
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2018.06.002
– volume: 264
  start-page: 1415
  year: 1994
  ident: R24-20250602
  article-title: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
  publication-title: Science
  doi: 10.1126/science.8197455
– volume: 86
  start-page: 1243
  year: 2006
  ident: R66-20250602
  article-title: Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis
  publication-title: Lab Invest
  doi: 10.1038/labinvest.3700487
– volume: 41
  start-page: 50
  year: 2018
  ident: R71-20250602
  article-title: Cepharanthine inhibits IFN-γ-induced CXCL10 by suppressing the JAK2/STAT1 signal pathway in human salivary gland ductal cells
  publication-title: Inflammation
  doi: 10.1007/s10753-017-0662-x
– volume: 59
  start-page: 817
  year: 2019
  ident: R103-20250602
  article-title: IgA vasculitis developed as an adverse effect of tofacitinib taken for rheumatoid arthritis: a case report
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.3668-19
– volume: 60
  start-page: 2066
  year: 2021
  ident: R106-20250602
  article-title: Treatment of Sjögren's syndrome: current therapy and future directions
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kez142
– volume: 43
  start-page: 519
  year: 2017
  ident: R4-20250602
  article-title: Neurologic manifestations of primary Sjögren syndrome
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/j.rdc.2017.06.002
– volume: 320
  start-page: 1360
  year: 2018
  ident: R18-20250602
  article-title: Diagnosis and management of rheumatoid arthritis: a review
  publication-title: JAMA
  doi: 10.1001/jama.2018.13103
– volume: 51
  start-page: 135
  year: 2018
  ident: R100-20250602
  article-title: Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development
  publication-title: Autoimmunity
  doi: 10.1080/08916934.2018.1446525
– volume: 2
  start-page: e22925
  year: 2013
  ident: R33-20250602
  article-title: The role of JAK-STAT signaling within the CNS
  publication-title: JAKSTAT
– volume: 179
  start-page: 1109
  year: 1994
  ident: R68-20250602
  article-title: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
  publication-title: J Exp Med
  doi: 10.1084/jem.179.4.1109
– volume: 2019
  start-page: 8142368
  year: 2019
  ident: R19-20250602
  article-title: Biologics in the treatment of lupus erythematosus: a critical literature review
  publication-title: Biomed Res Int
  doi: 10.1155/2019/8142368
– volume: 47
  start-page: 1211
  year: 2017
  ident: R52-20250602
  article-title: Clinical relevance of circulating anti-ENA and anti-dsDNA secreting cells from SLE patients and their dependence on STAT-3 activation
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201646872
– volume: 13
  start-page: 693
  year: 2017
  ident: R62-20250602
  article-title: JAK inhibition in inflammatory bowel disease
  publication-title: Expert Rev Clin Immunol
  doi: 10.1080/1744666X.2017.1291342
– volume: 183
  start-page: 97
  year: 2009
  ident: R87-20250602
  article-title: TGF-beta promotes Th17 cell development through inhibition of SOCS3
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0801986
– volume: 12
  start-page: 275
  year: 2018
  ident: R11-20250602
  article-title: Biomarkers for Sjögren's syndrome
  publication-title: Biomark Med
  doi: 10.2217/bmm-2017-0297
– volume: 58
  start-page: 182
  year: 2019
  ident: R77-20250602
  article-title: JAK inhibitors suppress innate epigenetic reprogramming: a promise for patients with Sjögren's syndrome
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-019-08743-y
– volume: 35
  start-page: 317
  year: 2017
  ident: R111-20250602
  article-title: Abatacept treatment of patients with primary Sjögren's syndrome results in a decrease of germinal centres in salivary gland tissue
  publication-title: Clin Exp Rheumatol
– volume: 73
  start-page: 1393
  year: 2014
  ident: R112-20250602
  article-title: Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204653
SSID ssj0025576
Score 2.4006636
SecondaryResourceType review_article
Snippet Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease with high prevalence and possible poor prognosis. Though the pathogenesis of pSS has not been...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2297
SubjectTerms Apoptosis
Arthritis
Autoimmune diseases
Cells
Cytokines
Deoxyribonucleic acid
DNA
Drugs
Epigenetics
Exocrine glands
Genes
Granulocytes
Humans
Immune system
Janus Kinases - metabolism
Kinases
Lymphocytes
Lymphoma
Nervous system
Pathogenesis
Proteins
Review
Ribonucleic acid
RNA
Signal Transduction
Sjogren's Syndrome - drug therapy
Sjogren's Syndrome - metabolism
Skin diseases
STAT Transcription Factors - metabolism
STAT1 Transcription Factor - metabolism
STAT3 Transcription Factor - metabolism
Tumor necrosis factor-TNF
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NatwwEBYlh1Aopemvm7SoUOhJxJYs2zpuQkNI2R6aDeQmxpbUbhPs0k0IfbG-QF4sM7ZsdttCLt2TWctgz4w833hmvmHsfeVySbRrwnhjMEBpQFR1KETuAMgdoU3Td8j55-L4LD851-dro76oJmygBx4Et-8UVJAqFwxQT2ZDw3acBmWgKhs8prcv-rwxmIqhltZlzFIWokAMNDbNmXL_cG4G0sL4k5oGha85pZ67_1-A8--6yUc3HeW0Vxd9SfuaYzp6wh5HRMlnw5PssAe-fcq25zFn_ozZL92l513gJ7NP4nQxW3Cq2QBqQ-c0j_gGfvFl2x92X-nNt1xxaB2fStDp2h8DKQU__X77GyP09sOKj1wHz9nZ0cfF4bGIYxVEg764FB49dg2u8AHq4HDL5wC6ropG66qUDQRXpSGTDiMpH0JeKOlxV6NSUVBamky9YFtt1_pXjCM8AJU6g4qB3LmsciWahKRKlDpTeZowNcrVNpFznEZfXNox943asH9qI2Fiuio-3j3rD0hl01pizO7_QDuy0Y7sfXaUsL1R4TZu45XFcFISP45RCXs3ncYNSFkVaH13TWuyHKN5xIEJeznYx3QnCj0_AkaZsGrDcjZudfNMu_zWk3wj7kUsmRYojA0js0N_LAlB0scoYUwUhaDG4vL1_xDGLnsoEcz1RYt6j21d_bz2bxB8XdVv-312B2PuJ1g
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1ba9RAFB60gghFvButMoLg09BkLknmSdZiKZX1wW5h38JJZtKulqRtWop_zD_gH_OcZJJ2VXSfwmYCybnM-c6cG2Nvc6cltV0T1luLDkoFIi_rVGgHQOYIZZrOIeef071Dvb80y3Dg1oW0ynFP7Ddq11Z0Rr6NyF5SqxKr3p-eCZoaRdHVMELjNrtDrctIqrPltcNlTBZilalIEQmNpXM2296Z26F1YfhJQ-PCb5imvoP_32Dnn9mTm1ctRba7b31i-w3ztPuA3Q-4ks8GQXjIbvnmEbs7D5Hzx6z40p543tZ8f_ZJHCxmC06ZG0DF6JymEl_Bd75q-sv2iPa_VcehcXxKRKdnT4fWFPzg688f6Kc37zo-djx4wg53Py529kQYriAqtMiZ8Gi3S3Cpr6GsHSq-BjBlnlbGIKUrqF0e14l06E_5utapkh51G1mLhDLSJuop22jaxj9nHEECqNhZLRPQziW5y1AwJOWjlInSccTUSNeiCp3HaQDGSTFGwJEbxe_ciJiYngqf95_1H4hl01rqm93_0Z4fFUENC6cgh1i52gJV-FY0uskZUBbyrMLriG2NDC-CMnfFtehF7M10G9WQYivQ-PaS1iQafXpEgxF7NsjH9CYK7T_CRhmxfE1y1l51_U6zOu5bfSP6RUQZp0iMNSErhipZIoKkIylhbSCFoPLi7MW_v-MluycRrPVJiWaLbVycX_pXCK4uyte9Bv0CxvEdvA
  priority: 102
  providerName: ProQuest
Title Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00029330-990000000-00577
https://www.ncbi.nlm.nih.gov/pubmed/37185152
https://www.proquest.com/docview/2872509693
https://www.proquest.com/docview/2814523727
https://pubmed.ncbi.nlm.nih.gov/PMC10538906
https://doaj.org/article/d3a8a03df9a6421c8cd4d5a39a87ccd4
Volume 136
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1ta9swED76AqVQxt7nrQsaDPZJI5bkF30YIy3tSkfKaBPINyNbcpst2F3S0vWP7Q_sj-3Ob8xby_IhmFgC5e6ku9PdPQfwNrZKEOwa105rdFAyw-M0D7myxpA6Qpmme8jxSXg0VcezYLYGbc_WhoCrO1076ic1XS7e__h--xE3_IcWgHF_rGsYwuYjAqnXYRN1U0Q9Dcaqiyug_RyFbQHdPTO3YUvigY16XvR0VQXpf5cd-m865c5NSaHu1bcq0_0PfXX4EB40hiYb1ZLxCNZc8Ri2xk0o_Qkkp-XCsTJnx6PP_GwymjBK5TBUnc6oTfGNuWXzonosz-lAnK-YKSzrMtNp7mWNVcHOvv76iY578W7FWgiEpzA9PJjsH_Gm2wLPUEVH3KEiT40NXW7S3OJJoIwJ0jjMgiCORGZyGw9zX1h0sFyeq1AKh5sdeY00C4T25TPYKMrCvQCGVoORQ6uV8I2y1o9thJIiKEEl9aUaeiBbuiZZA0VOHTEWSRsSR8YkfzPGA97Nav7ef8bvEcu6sQSkXf1QLs-TZl8mVprYDKXNtaGS34x6OdnASG3iKMNnD3ZbhietcCboZQqCzdHSgzfda9yXFGwxhSuvaYyv0MlH89CD57V8dCtp5cuDuCc5vaX23xTziwr7G81hNDGHIRKjJ2RJXTZLRBB0R8W1bkjBqd44ennvIl7BtkDDrUpQDHZh42p57V6joXWVDmA9mkUD2Nw7OPlyOqiuK_D708wfVLvqN6o6I2U
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQrwxFFgkEKdV7V2v7T0gFApV2jQ90FTKzay96xCo7JK0ivqnOPIH-GPM-JE2gODUnKx4nXhnZne-2XkBvExsKKjsGtdOazRQcsOTrIh4aI0hdYQyTeeQw_2ofxjujtV4Db53uTAUVtntifVGbauczsg3EdkLKlWi5dvjb5y6RpF3tWuh0YjFwJ0t0GSbv9l5j_x9JcT2h9FWn7ddBXiOqijmDhVWZmzkCpMVFiU-NEZlSZQrhX-Rm8ImfhEIi4aEK4owksKhUOOclNRK6EDi716Bq6h4fTL24vG5gadU3PpGIx4h8upS9XS8uTXUTanE9iMUtSe_oArrjgF_g7l_RmveXFTkSZ9_rQPpL6jD7dtwq8WxrNcI3h1Yc-VduDZsPfX3IP1YHTlWFWy3N-AHo96IUaSIoeR3Rl2QF-aMTcv6sprQfjudM1Natgx8p2ePm1IY7ODLzx-TmStfz1lXYeE-HF4K2R_AelmV7hEwBCVG-laHIjChtUFiYxREQfEvWSBD3wPZ0TXN20rn1HDjKO087siN9HdueMCXT7XT-8_4d8Sy5Viq011_Uc0mabvsUytNYnxpC20oozinVlFWGalNEud47cFGx_C03Tzm6bmoe_BieRuXPflyTOmqUxoThEpIRJ8ePGzkY_kmEvEGwlThQbIiOSuvunqnnH6uS4sj2kYE60dIjBUhS5usXCKCoCMwrnVLCk7pzPHjf8_jOVzvj4Z76d7O_uAJ3BAIFOuASLUB6yezU_cUgd1J9qxeTQw-Xfby_QU4zlpV
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWrrRCQog3gQWMBOUU1NhxmhxyKH2w29LuinZhOQUndkphlayaLlX_GH-AP8ZMXqI8hDhsLrEap3XH45lv7HkQ8sxVNsO0a6anPQ8MlEiabhg7pq2kRHUEPI37kOOJc3BiD0_F6Q6pijVg8Fl2_hJvuZjGBpbDQbtw5g-nze60639oTvrvp_6kedx53c-3qdFJonncG_ibZs9Pv8arZu_Ir_IzdsdekaWwvJjgXhn5MdKbNdh4mX_YA4Z4ztigP-semGUZAjMC3dU2NWi4UCpHxzKMFSwRW0oRuk4khNtmkYyV24otpsDy0HFsO5xpWAVABPgdwTyLw_deIbuuC5ZDg-wevev3e7VNKERR_07YYBM6tlVF9_1l3FvaMy8y8Cdk_LuD57V1iofv2Zfc9_4nDTq4Qa6X0Jd2Cl69SXZ0covsjcvD_dskeJueaZrGdNgZmdNZZ0bRuURivDzFwslruaGLJG-mcxTRi4zKRNHaVx7fPS-yZ9Dp5-_f5kudvMholZThDjm5FMLfJY0kTfR9QgHHSN5Sns0saStluaoNvMvQZSa0uN0yCK_oGkRlcnSs0XEWVIf0MBvBr7NhELN-q_x7_-j_Cqes7oupvfMP0uU8KCVFoLh0ZYur2JMYhBxhdSklJPek246gbZD9asKDUt5kAdi9DBP5eNwgT-vHICnw-EcmOr3APpYtGAfAapB7BX_UI-EAUQDZMoO4W5yzNdTtJ8niU56NHAA6gN6WA8TYYrKgCORFIjDcNTM9rySFiRHQ7Qf_2f8J2YMVHrw5nIwekqsMsGbuUyn2SWO1vNCPABuuwsfl-qLk42Uv6R9hFmps
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+JAK-STAT+signaling+pathway+in+pathogenesis+and+treatment+of+primary+Sj%C3%B6gren%27s+syndrome&rft.jtitle=Chinese+medical+journal&rft.au=Li%2C+Mucong&rft.au=Li%2C+Mengtao&rft.au=Qiao%2C+Lin&rft.au=Wu%2C+Chanyuan&rft.date=2023-10-05&rft.eissn=2542-5641&rft.volume=136&rft.issue=19&rft.spage=2297&rft_id=info:doi/10.1097%2FCM9.0000000000002539&rft_id=info%3Apmid%2F37185152&rft.externalDocID=37185152
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2542-5641&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2542-5641&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2542-5641&client=summon